S.L.A. Pharma AG

Quick facts

Phase 3 pipeline

• Diltiazem hydrochloride 4% cream · Dermatology / Pain Management
  Diltiazem is a calcium channel blocker that reduces smooth muscle contraction and improves blood flow when applied topically to affected tissues.
• Eicosapentaenoic acid gastro-resistant capsules · Cardiovascular
  Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid that reduces triglycerides and modulates inflammatory pathways in cardiovascular disease.

Phase 2 pipeline

• Metronidazole 10% ointment

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• S.L.A. Pharma AG portfolio CI brief
• S.L.A. Pharma AG pipeline updates RSS